生物
谷氨酰胺分解
癌症研究
谷氨酰胺
转录组
ATF4
癌细胞
癌症
细胞生物学
细胞凋亡
生物化学
未折叠蛋白反应
基因
遗传学
基因表达
氨基酸
作者
Bo Kyung Yoon,Hyeonhui Kim,Tae Gyu Oh,Sunhwa Oh,Sugyeong Jo,Min Ki Kim,Kyu-Hye Chun,Nahee Hwang,Suji Lee,Seok Min Jin,Annette R. Atkins,Ruth T. Yu,Michael Downes,Jae-Woo Kim,Hyun Kyung Kim,Ronald M. Evans,Jae‐Ho Cheong,Sungsoon Fang
标识
DOI:10.1073/pnas.2217826120
摘要
Molecular classification of gastric cancer (GC) identified a subgroup of patients showing chemoresistance and poor prognosis, termed SEM (Stem-like/Epithelial-to-mesenchymal transition/Mesenchymal) type in this study. Here, we show that SEM-type GC exhibits a distinct metabolic profile characterized by high glutaminase (GLS) levels. Unexpectedly, SEM-type GC cells are resistant to glutaminolysis inhibition. We show that under glutamine starvation, SEM-type GC cells up-regulate the 3 phosphoglycerate dehydrogenase (PHGDH)-mediated mitochondrial folate cycle pathway to produce NADPH as a reactive oxygen species scavenger for survival. This metabolic plasticity is associated with globally open chromatin structure in SEM-type GC cells, with ATF4/CEBPB identified as transcriptional drivers of the PHGDH-driven salvage pathway. Single-nucleus transcriptome analysis of patient-derived SEM-type GC organoids revealed intratumoral heterogeneity, with stemness-high subpopulations displaying high GLS expression, a resistance to GLS inhibition, and ATF4/CEBPB activation. Notably, coinhibition of GLS and PHGDH successfully eliminated stemness-high cancer cells. Together, these results provide insight into the metabolic plasticity of aggressive GC cells and suggest a treatment strategy for chemoresistant GC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI